Mavyret

AbbVie Inc.🇺🇸 United States

FDA Page

Effective Date: Jun 25, 2025
Approval ID: 7bf99777-0401-9095-8645-16c6e907fcc0
Products: 2 registered
Version: 201

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use MAVYRET safely and effectively. See full prescribing information for MAVYRET. MAVYRET (glecaprevir and pibr entasvir) tablets, for oral use MAVYRET (glecaprevir and pibrentasvir) oral pellets Initial U.S. Approval: 2017

Quick Stats

Total Products2

Labelers2

Label Sections24

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.